Literature DB >> 14743967

Identification of phase I and phase II metabolites of Guanfu base A hydrochloride in human urine.

J Y A1, G J Wang, J G Sun, Y C Gu, M S Wu, J H Liu.   

Abstract

Guanfu base A is a novel arrhythmic drug candidate isolated from the tuber of a traditional Chinese herb. Phase I and Phase II metabolites of Guanfu base A (GFA) Hydrochloride were studied in human urine by means of liquid chromatography mass spectrometry (LC/MSD) and tandem mass spectrometry (MS/MS). For phase I metabolites, Guanfu base I (GFI) was separated by HPLC and identified by comparison with authentic reference for their retention times, molecular ion peaks, fragment ions, and UV spectra. GFA oxide was also indicated to exist in human urine. For phase II metabolites, after human urine was treated either with glucuronidase or sulfatase, GFA occured in the chromatograms. It was suggested that there were GFA glucuronide and GFA sulfate in human urine. Further more, positive molecular ions, m/z 606 and m/z 510, of the two conjugates were detected in human urine by LC/MSD. In addition, characteristic ion of m/z 606 was identified as the precursor ion of m/z 177 [Glucuronic acid+H]+ by using MS/MS. Characteristic ion of m/z 430 [GFA+H]+ was also identified as a product ion of m/z 606 [GFA glucuronide+H]+. It was concluded that there were GFI. GFA oxide, GFA glucuronide and GFA sulfate in human urine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14743967     DOI: 10.1007/BF03220178

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  6 in total

1.  [Effects of guan-fu base A on fast response action potentials of papillary muscles of guinea pigs].

Authors:  H Z Chen; P K Gu; L Zhang; Z J Jin; W Z Chen
Journal:  Zhongguo Yao Li Xue Bao       Date:  1989-09

2.  [Anti-arrhythmia effects of guan-fu base A].

Authors:  W Z Chen; Y L Dong; Y F Zhang; G S Ding
Journal:  Zhongguo Yao Li Xue Bao       Date:  1983-12

3.  Identification of guanfu base A hydrochloride phase I and phase II metabolites in rat bile by liquid chromatography mass spectrometry.

Authors:  Ji-Ye A; Guang-Ji Wang; Min-Shu Wu; Jing-Han Liu
Journal:  Acta Pharmacol Sin       Date:  2002-11       Impact factor: 6.150

4.  [Effects of guan-fu base A on spontaneous rate of isolated sinoatrial node of guinea pig].

Authors:  Y P Wang; W Z Chen; P K Gu
Journal:  Zhongguo Yao Li Xue Bao       Date:  1990-11

5.  [Study on the metabolites of guanfu base A hydrochloride in rat urine by high performance liquid chromatograph-mass spectrum].

Authors:  Ji-ye A; Guang-ji Wang; Xiao-quan Liu; Dan-yun Jiang; Jing-han Liu
Journal:  Yao Xue Xue Bao       Date:  2002-04

6.  [Effects of guan-fu base a on experimental cardiac arrhythmias and myocardial contractility].

Authors:  Y L Dong; W Z Chen
Journal:  Yao Xue Xue Bao       Date:  1995
  6 in total
  4 in total

Review 1.  Biological screening of natural products and drug innovation in China.

Authors:  Ming-Wei Wang; Xiaojiang Hao; Kaixian Chen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-06-29       Impact factor: 6.237

2.  Safety, heart specificity, and therapeutic effect evaluation of Guanfu base A-loaded solid nanolipids in treating arrhythmia.

Authors:  Fei Xiong; Kunliang Liu; Sha Liu; Jianjun Chen; Jinghan Liu; Hao Wang; Ning Gu
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

3.  Knockdown of FUSE binding protein 1 enhances the sensitivity of epithelial ovarian cancer cells to carboplatin.

Authors:  Jinli Zhang; Xifeng Xiong; Xing Hua; Wenjuan Cao; Shengnan Qin; Libing Dai; Peihong Liang; Huiling Zhang; Zhihe Liu
Journal:  Oncol Lett       Date:  2017-09-15       Impact factor: 2.967

4.  FBP1 promotes ovarian cancer development through the acceleration of cell cycle transition and metastasis.

Authors:  Xifeng Xiong; Jinli Zhang; Xing Hua; Wenjuan Cao; Shengnan Qin; Libing Dai; Wei Liu; Zhi Zhang; Xiaojian Li; Zhihe Liu
Journal:  Oncol Lett       Date:  2018-06-01       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.